Efficacy - RINVOQ® (upadacitinib) for Ulcerative Colitis
Serum biomarkers confirming stable remission in inflammatory bowel disease | Scientific Reports
Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease | BMC Gastroenterology | Full Text
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis? - ScienceDirect
Therapeutic guidelines on ulcerative colitis: A GRADE methodology based effort of GETECCU | Gastroenterología y Hepatología
Efficacy Data | SKYRIZI® (risankizumab-rzaa)
Ulcerative Colitis (UC): Efficacy | STELARA® (ustekinumab) HCP
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
Biomedicines | Free Full-Text | Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
European Crohn´s and Colitis Organisation - ECCO - P193 Validation of the two-item UC patient-reported outcome (PRO2) against the simple clinical colitis activity index (SCCAI), measures of biochemical disease activity and quality
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers - Fabiana Castiglione, Nicola Imperatore, Anna Testa, Roberto de Sire, Olga Maria Nardone, Simona Ricciolino, Imma Di
European Crohn´s and Colitis Organisation - ECCO - Diet in the Treatment Paradigm of Crohn's Disease: New Evidence, New Strategies
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort | Scientific Reports
Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease | NEJM Evidence
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study - Clinical Nutrition ESPEN
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Efficacy - RINVOQ® (upadacitinib) for Ulcerative Colitis
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
Exabis Library:
Definition of remission of ra | PPT
Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study
